These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1647453)

  • 1. [Studies on collagenase inhibitors. III. Inhibitory effects of anthracyclines on bacterial collagenase].
    Tanaka T; Metori K; Mineo S; Matsumoto H; Satoh T
    Yakugaku Zasshi; 1991 Jan; 111(1):70-2. PubMed ID: 1647453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of inhibitory effects of doxorubicin on collagenase using a bovine placentome model.
    Fecteau KA; Eiler H
    In Vivo; 1998; 12(5):485-8. PubMed ID: 9827355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential resistance to anthracyclines in P-glycoprotein-expressing human hepatoma cells.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):89-92. PubMed ID: 9520154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on collagenase inhibitors. II. Inhibitory effects of anthraquinones on bacterial collagenase].
    Tanaka T; Metori K; Mineo S; Matsumoto H; Satoh T
    Yakugaku Zasshi; 1990 Sep; 110(9):688-92. PubMed ID: 2175789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of collagenase by aranciamycin and aranciamycin derivatives.
    Bols M; Binderup L; Hansen J; Rasmussen P
    J Med Chem; 1992 Jul; 35(15):2768-71. PubMed ID: 1322986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
    Muszyńska A; Wolczyński S; Pałka J
    Eur J Pharmacol; 2001 Jan; 411(1-2):17-25. PubMed ID: 11137854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
    Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
    Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract]   [Full Text] [Related]  

  • 10. Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.
    Lehne G; De Angelis P; Clausen OP; Rugstad HE
    Br J Cancer; 1996 Dec; 74(11):1719-29. PubMed ID: 8956784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis.
    Dartsch DC; Schaefer A; Boldt S; Kolch W; Marquardt H
    Apoptosis; 2002 Dec; 7(6):537-48. PubMed ID: 12370496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics and action mechanism of anthracyclines].
    Fukushima T; Ueda T; Nakamura T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):445-50. PubMed ID: 1558393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of alpha-tocopherol and calcium calmodulin-stimulated phosphodiesterase activity in vitro by anthracyclines.
    Nwankwoala RN; West WL
    Clin Exp Pharmacol Physiol; 1988 Nov; 15(11):805-14. PubMed ID: 3229005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract]   [Full Text] [Related]  

  • 15. [Purification and study of some properties of a collagenase produced by Empedobacter collagenolyticum].
    Labadie J; Montel MC
    Biochimie; 1982 Jan; 64(1):49-53. PubMed ID: 6279175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiac actions of doxorubicin, pirarubicin and aclarubicin in isolated guinea-pig heart.
    Temma K; Akera T; Chugun A; Kondo H; Hagane K; Hirano S
    Eur J Pharmacol; 1993 Apr; 234(2-3):173-81. PubMed ID: 8482324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basement membrane collagen-degrading activity from a malignant tumor is inhibited by anthracycline antibiotics.
    Karakiulakis G; Missirlis E; Maragoudakis ME
    Biochim Biophys Acta; 1990 Aug; 1035(2):218-22. PubMed ID: 2168213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Burres NS; Myers MT; Sartorelli AC
    Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H; Nguyen-Ba G; Lampidis TJ
    Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the field of antitumour anthracyclines.
    Monneret C
    Eur J Med Chem; 2001 Jun; 36(6):483-93. PubMed ID: 11525839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.